Mechanisms of NLRP3 inflammasome-mediated hepatic stellate cell activation: Therapeutic potential for liver fibrosis

Higashi, 2017, Hepatic stellate cells as key target in liver fibrosis, Adv Drug Deliv Rev, 121, 27, 10.1016/j.addr.2017.05.007 Friedman, 2004, Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications, Nat Clin Pract Gastroenterol Hepatol, 1, 98, 10.1038/ncpgasthep0055 Bataller, 2005, Liver fibrosis, J Clin Invest, 115, 209, 10.1172/JCI24282 Mokdad, 2014, Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis, BMC Med, 12, 145, 10.1186/s12916-014-0145-y World Health Organization, 2018 Tsuchida, 2017, Mechanisms of hepatic stellate cell activation, Nat Rev Gastroenterol Hepatol, 14, 397, 10.1038/nrgastro.2017.38 Calabrese, 2010, Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders, Antioxidants Redox Signal, 13, 1763, 10.1089/ars.2009.3074 Rockey, 2015, Fibrosis--a common pathway to organ injury and failure, N Engl J Med, 372, 1138, 10.1056/NEJMra1300575 Koyama, 2017, Liver inflammation and fibrosis, J Clin Invest, 127, 55, 10.1172/JCI88881 Schroder, 2010, The inflammasomes, Cell, 140, 821, 10.1016/j.cell.2010.01.040 Guo, 2015, Inflammasomes: mechanism of action, role in disease, and therapeutics, Nat Med, 21, 677, 10.1038/nm.3893 Strowig, 2012, Inflammasomes in health and disease, Nature, 481, 278, 10.1038/nature10759 Alegre, 2017, Inflammasomes in liver fibrosis, Semin Liver Dis, 37, 119, 10.1055/s-0037-1601350 Szabo, 2012, Inflammasomes in liver diseases, J Hepatol, 57, 642, 10.1016/j.jhep.2012.03.035 Shi, 2015, Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death, Nature, 526, 660, 10.1038/nature15514 Miao, 2011, Caspase-1-induced pyroptotic cell death, Immunol Rev, 243, 206, 10.1111/j.1600-065X.2011.01044.x de Zoete, 2014, Inflammasomes, Cold Spring Harbor Perspect Biol, 6, a016287, 10.1101/cshperspect.a016287 Stienstra, 2011, Inflammasome is a central player in the induction of obesity and insulin resistance, Proc Natl Acad Sci U S A, 108, 15324, 10.1073/pnas.1100255108 Nozaki, 2019, A licence to kill during inflammation, Nature, 570, 316, 10.1038/d41586-019-01764-9 Benetti, 2013, The NLRP3 inflammasome as a novel player of the intercellular crosstalk in metabolic disorders, Mediat Inflamm, 2013, 678627, 10.1155/2013/678627 Schmid-Burgk, 2016, A genome-wide CRISPR (clustered regularly interspaced short palindromic repeats) screen identifies NEK7 as an essential component of NLRP3 inflammasome activation, J Biol Chem, 291, 103, 10.1074/jbc.C115.700492 Kelley, 2019, The NLRP3 inflammasome: an overview of mechanisms of activation and regulation, Int J Mol Sci, 20, 3328, 10.3390/ijms20133328 Bauernfeind, 2009, Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression, J Immunol, 183, 787, 10.4049/jimmunol.0901363 Perregaux, 1994, Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity, J Biol Chem, 269, 15195, 10.1016/S0021-9258(17)36591-2 Lee, 2012, The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP, Nature, 492, 123, 10.1038/nature11588 Domingo-Fernández, 2017, The intracellular chloride channel proteins CLIC1 and CLIC4 induce IL-1β transcription and activate the NLRP3 inflammasome, J Biol Chem, 292, 12077, 10.1074/jbc.M117.797126 Hornung, 2008, Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization, Nat Immunol, 9, 847, 10.1038/ni.1631 Tschopp, 2010, NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?, Nat Rev Immunol, 10, 210, 10.1038/nri2725 Tao, 2020, Autophagic-CTSB-inflammasome axis modulates hepatic stellate cells activation in arsenic-induced liver fibrosis, Chemosphere, 242, 124959, 10.1016/j.chemosphere.2019.124959 Zhou, 2011, A role for mitochondria in NLRP3 inflammasome activation, Nature, 469, 221, 10.1038/nature09663 Groß, 2016, K+ efflux-independent NLRP3 inflammasome activation by small molecules targeting mitochondria, Immunity, 45, 761, 10.1016/j.immuni.2016.08.010 Cabrera, 2017, Andrographolide ameliorates inflammation and fibrogenesis and attenuates inflammasome activation in experimental non-alcoholic steatohepatitis, Sci Rep, 7, 3491, 10.1038/s41598-017-03675-z Wang, 2016, Nod-like receptor protein 3 inflammasome activation by Escherichia coli RNA induces transforming growth factor beta 1 secretion in hepatic stellate cells, Bosn J Basic Med Sci, 16, 126 Mridha, 2017, NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice, J Hepatol, 66, 1037, 10.1016/j.jhep.2017.01.022 Lu, 2017, NLRP3 inflammasome activation results in liver inflammation and fibrosis in mice infected with Schistosoma japonicum in a Syk-dependent manner, Sci Rep, 7, 8120, 10.1038/s41598-017-08689-1 Boaru, 2012, Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease, J Inflamm, 9, 49, 10.1186/1476-9255-9-49 Reiter, 2016, Role of interleukin-1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4(-/-) mouse model, World J Hepatol, 8, 401, 10.4254/wjh.v8.i8.401 Miura, 2010, Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1 beta in mice, Gastroenterology, 139, 323, 10.1053/j.gastro.2010.03.052 Tang, 2013, Interleukin-1β upregulates matrix metalloproteinase-13 gene expression via c-Jun N-terminal kinase and p38 MAPK pathways in rat hepatic stellate cells, Mol Med Rep, 8, 1861, 10.3892/mmr.2013.1719 Dwivedi, 2018, Glibenclamide protects against thioacetamide-induced hepatic damage in Wistar rat: investigation on NLRP3, MMP-2, and stellate cell activation, Naunyn-Schmiedeberg’s Arch Pharmacol, 391, 1257, 10.1007/s00210-018-1540-2 El-Kashef, 2019, Sitagliptin ameliorates thioacetamide-induced acute liver injury via modulating TLR4/NF-KB signaling pathway in mice, Life Sci, 228, 266, 10.1016/j.lfs.2019.05.019 Shi, 2018, Activation of Nrf 2 pathway and inhibition of NLRP3 inflammasome activation contribute to the protective effect of chlorogenic acid on acute liver injury, Int Immunopharm, 54, 125, 10.1016/j.intimp.2017.11.007 Yang, 2017, Chlorogenic acid inhibits liver fibrosis by blocking the miR-21-regulated TGF-β1/Smad 7 signaling pathway in vitro and in vivo, Front Pharmacol, 8, 929, 10.3389/fphar.2017.00929 Watanabe, 2009, Inflammasome-mediated regulation of hepatic stellate cells, Am J Physiol Gastrointest Liver Physiol, 296, G1248, 10.1152/ajpgi.90223.2008 Wree, 2014, NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice, Hepatology, 59, 898, 10.1002/hep.26592 Inzaugarat, 2019, NLR family pyrin domain-containing 3 inflammasome activation in hepatic stellate cells induces liver fibrosis in mice, Hepatology, 69, 845, 10.1002/hep.30252 Duan, 2017, Palmitic acid elicits hepatic stellate cell activation through inflammasomes and hedgehog signaling, Life Sci, 176, 42, 10.1016/j.lfs.2017.03.012 Wree, 2014, NLRP3 inflammasome activation is required for fibrosis development in NAFLD, J Mol Med (Berl), 92, 1069, 10.1007/s00109-014-1170-1 Wree, 2018, NLRP3 inflammasome driven liver injury and fibrosis: roles of IL-17 and TNF in mice, Hepatology, 67, 736, 10.1002/hep.29523 Li, 2020, Role of aldosterone in the activation of primary mice hepatic stellate cell and liver fibrosis via NLRP3 inflammasome, J Gastroenterol Hepatol, 35, 1069, 10.1111/jgh.14961 Talwani, 2011, Infectious diseases and the liver, Clin Liver Dis, 15, 111, 10.1016/j.cld.2010.09.002 Zhang, 2019, NLRP3 inflammasome activation from Kupffer cells is involved in liver fibrosis of Schistosoma japonicum-infected mice via NF-κB, Parasites Vectors, 12, 29, 10.1186/s13071-018-3223-8 Liu, 2019, Taurine alleviates Schistosoma-induced liver injury by inhibiting the TXNIP/NLRP3 inflammasome signal pathway and pyroptosis, Infect Immun, 87, 10.1128/IAI.00732-19 Meng, 2016, Activation of NLRP3 inflammasomes in mouse hepatic stellate cells during Schistosoma, J Infect Oncotarget, 7, 39316, 10.18632/oncotarget.10044 Chen, 2019, Activation of the NLRP3 and AIM2 inflammasomes in a mouse model of Schistosoma mansoni infection, J Helminthol, 94, e72, 10.1017/S0022149X19000622 Jiang, 2017, Potentiation of hepatic stellate cell activation by extracellular ATP is dependent on P2X7R-mediated NLRP3 inflammasome activation, Pharmacol Res, 117, 82, 10.1016/j.phrs.2016.11.040 Han, 2018, Ginsenoside 25-OCH3-PPD promotes activity of LXRs to ameliorate P2X7R-mediated NLRP3 inflammasome in the development of hepatic fibrosis, J Agric Food Chem, 66, 7023, 10.1021/acs.jafc.8b01982 Cinar, 2016, Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis, JCI Insight, 1, e87336, 10.1172/jci.insight.87336 Wu, 2015, Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating NLRP3 inflammasome pathway, IUBMB Life, 67, 312, 10.1002/iub.1348 Monaco, 2004, Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis, Proc Natl Acad Sci U S A, 101, 5634, 10.1073/pnas.0401060101 Sun, 2008, NF-kappaB signaling, liver disease and hepatoprotective agents, Oncogene, 27, 6228, 10.1038/onc.2008.300 Dong, 2020, Palmitic acid stimulates NLRP3 inflammasome activation through TLR4-NF-κB signal pathway in hepatic stellate cells, Ann Transl Med, 8, 168, 10.21037/atm.2020.02.21 Zhao, 2020, TAF and TDF attenuate liver fibrosis through NS5ATP9, TGFβ1/Smad 3, and NF-κB/NLRP3 inflammasome signaling pathways, Hepatol Int, 14, 145, 10.1007/s12072-019-09997-6 Boaru, 2015, NLRP3 inflammasome expression is driven by NF-κB in cultured hepatocytes, Biochem Biophys Res Commun, 458, 700, 10.1016/j.bbrc.2015.02.029 Kim, 2020, Hemistepsin A alleviates liver fibrosis by inducing apoptosis of activated hepatic stellate cells via inhibition of nuclear factor-κB and Akt, Food Chem Toxicol, 135, 111044, 10.1016/j.fct.2019.111044 Huang, 2005, The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP, Cell, 122, 421, 10.1016/j.cell.2005.06.007 Elosegui-Artola, 2017, Force triggers YAP nuclear entry by regulating transport across nuclear pores, Cell, 171, 1397, 10.1016/j.cell.2017.10.008 Manmadhan, 2019, Hippo signaling in the liver - a long and ever-expanding story, Front Cell Dev Biol, 7, 33, 10.3389/fcell.2019.00033 Wang, 2020, Calcipotriol inhibits NLRP3 signal through YAP1 activation to alleviate cholestatic liver injury and fibrosis, Front Pharmacol, 11, 200, 10.3389/fphar.2020.00200 Jin, 2017, Inhibition of YAP signaling contributes to senescence of hepatic stellate cells induced by tetramethylpyrazine, Eur J Pharmaceut Sci, 96, 323, 10.1016/j.ejps.2016.10.002 Li, 2018, The inhibition of Hippo/Yap signaling pathway is required for magnesium isoglycyrrhizinate to ameliorate hepatic stellate cell inflammation and activation, Biomed Pharmacother, 106, 83, 10.1016/j.biopha.2018.06.102 Alsamman, 2020, Targeting acid ceramidase inhibits YAP/TAZ signaling to reduce fibrosis in mice, Sci Transl Med, 12, eaay8798, 10.1126/scitranslmed.aay8798 Liu, 2019, Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury, J Hepatol, 71, 719, 10.1016/j.jhep.2019.05.029 Belgacemi, 2020, Airway epithelial cell differentiation relies on deficient Hedgehog signalling in COPD, EBioMedicine, 51, 102572, 10.1016/j.ebiom.2019.11.033 Cigna, 2012, The hedgehog system machinery controls transforming growth factor-β-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis, Am J Pathol, 181, 2126, 10.1016/j.ajpath.2012.08.019 Li, 2021, Functional crosstalk between myeloid Foxo 1-β-catenin axis and Hedgehog/Gli 1 signaling in oxidative stress response, Cell Death Differ, 28, 1705, 10.1038/s41418-020-00695-7 Sheng, 2021, CD47-mediated hedgehog/SMO/GLI1 signaling promotes mesenchymal stem cell immunomodulation in mouse liver inflammation, Hepatology, 74, 1560, 10.1002/hep.31831 Ma, 2021, Procyanidin B2 alleviates liver injury caused by cold stimulation through Sonic hedgehog signalling and autophagy, J Cell Mol Med, 25, 8015, 10.1111/jcmm.16733 Weiskirchen, 2014, Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology, Hepatobiliary Surg Nutr, 3, 344 Miura, 2013, Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice, Hepatology, 57, 577, 10.1002/hep.26081 Zhang, 2016, Angiotensin(1-7) attenuated Angiotensin II-induced hepatocyte EMT by inhibiting NOX-derived H2O2-activated NLRP3 inflammasome/IL-1β/Smad circuit, Free Radic Biol Med, 97, 531, 10.1016/j.freeradbiomed.2016.07.014 Cai, 2016, Angiotensin-(1-7) improves liver fibrosis by regulating the NLRP3 inflammasome via redox balance modulation, Antioxidants Redox Signal, 24, 795, 10.1089/ars.2015.6498 Gong, 2016, Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis, Oncotarget, 7, 83951, 10.18632/oncotarget.13796 DeSantis, 2013, Alcohol-induced liver injury is modulated by Nlrp3 and Nlrc4 inflammasomes in mice, Mediat Inflamm, 2013, 751374, 10.1155/2013/751374 Ganz, 2011, Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver, World J Gastroenterol, 17, 4772, 10.3748/wjg.v17.i43.4772 Bajaj, 2019, Alcohol, liver disease and the gut microbiota, Nat Rev Gastroenterol Hepatol, 16, 235, 10.1038/s41575-018-0099-1 McGill, 2012, The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation, J Clin Invest, 122, 1574, 10.1172/JCI59755 Koo, 2021, Signaling nodes associated with endoplasmic reticulum stress during NAFLD progression, Biomolecules, 11, 242, 10.3390/biom11020242 Bozaykut, 2016, Endoplasmic reticulum stress related molecular mechanisms in nonalcoholic steatohepatitis, Mech Ageing Dev, 157, 17, 10.1016/j.mad.2016.07.001 Wang, 2020, Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease, Lipids Health Dis, 19, 72, 10.1186/s12944-020-01210-0 Swanson, 2019, The NLRP3 inflammasome: molecular activation and regulation to therapeutics, Nat Rev Immunol, 19, 477, 10.1038/s41577-019-0165-0 Song, 2021, Biological functions of NLRP3 inflammasome: a therapeutic target in inflammatory bowel disease, Cytokine Growth Factor Rev, 60, 61, 10.1016/j.cytogfr.2021.03.003 Bahia, 2015, Interleukin-1 receptor associated kinase inhibitors: potential therapeutic agents for inflammatory-and immune-related disorders, Cell Signal, 27, 1039, 10.1016/j.cellsig.2015.02.025 Mangan, 2018, Targeting the NLRP3 inflammasome in inflammatory diseases, Nat Rev Drug Discov, 17, 588, 10.1038/nrd.2018.97 Huang, 2016, Drugging the undruggables: exploring the ubiquitin system for drug development, Cell Res, 26, 484, 10.1038/cr.2016.31 Song, 2017, NLRP3 phosphorylation is an essential priming event for inflammasome activation, Mol Cell, 68, 185, 10.1016/j.molcel.2017.08.017 Stutz, 2017, NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain, J Exp Med, 214, 1725, 10.1084/jem.20160933 Mortimer, 2016, NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations, Nat Immunol, 17, 1176, 10.1038/ni.3538 Guo, 2016, Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome, Immunity, 45, 802, 10.1016/j.immuni.2016.09.008 Barry, 2018, SUMO-mediated regulation of NLRP3 modulates inflammasome activity, Nat Commun, 9, 3001, 10.1038/s41467-018-05321-2 Thiagalingam, 2003, Histone deacetylases: unique players in shaping the epigenetic histone code, Ann N Y Acad Sci, 983, 84, 10.1111/j.1749-6632.2003.tb05964.x Khan, 2016, Anti-fibrotic effects of valproic acid: role of HDAC inhibition and associated mechanisms, Epigenomics, 8, 1087, 10.2217/epi-2016-0034 Grunstein, 1997, Histone acetylation in chromatin structure and transcription, Nature, 389, 349, 10.1038/38664 He, 2020, An acetylation switch of the NLRP3 inflammasome regulates aging-associated chronic inflammation and insulin resistance, Cell Metabol, 31, 580, 10.1016/j.cmet.2020.01.009 Dempsey, 2020, Sirtuin regulation of NLRP3, Nat Immunol, 21, 358 Yan, 2020, Pharmacological inhibition of HDAC6 attenuates NLRP3 inflammatory response and protects dopaminergic neurons in experimental models of Parkinson's disease, Front Aging Neurosci, 12, 78, 10.3389/fnagi.2020.00078 Pinto, 2018, Anti-oxidant and anti-inflammatory activity of ketogenic diet: new perspectives for neuroprotection in alzheimer's disease, Antioxidants, 7, 63, 10.3390/antiox7050063 Khan, 2014, Sodium butyrate, a HDAC inhibitor ameliorates eNOS, iNOS and TGF-β1-induced fibrogenesis, apoptosis and DNA damage in the kidney of juvenile diabetic rats, Food Chem Toxicol, 73, 127, 10.1016/j.fct.2014.08.010 Khan, 2016, Sodium butyrate reduces insulin-resistance, fat accumulation and dyslipidemia in type-2 diabetic rat: a comparative study with metformin, Chem Biol Interact, 254, 124, 10.1016/j.cbi.2016.06.007 Kanika, 2015, Sodium butyrate ameliorates L-arginine-induced pancreatitis and associated fibrosis in Wistar rat: role of inflammation and nitrosative stress, J Biochem Mol Toxicol, 29, 349, 10.1002/jbt.21698 Khan, 2016, Valproic acid reduces insulin-resistance, fat deposition and FOXO1-mediated gluconeogenesis in type-2 diabetic rat, Biochimie, 125, 42, 10.1016/j.biochi.2016.02.014 Khan, 2015, Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the inhibition of histone deacetylases in diabetic rat, Exp Mol Pathol, 98, 230, 10.1016/j.yexmp.2015.01.003 Khan, 2015, Valproate attenuates the proteinuria, podocyte and renal injury by facilitating autophagy and inactivation of NF-κB/iNOS signaling in diabetic rat, Biochimie, 110, 1, 10.1016/j.biochi.2014.12.015 Jesus, 2014, IL-1 blockade in autoinflammatory syndromes, Annu Rev Med, 65, 223, 10.1146/annurev-med-061512-150641 Calabrese, 2002, Anakinra treatment of patients with rheumatoid arthritis, Ann Pharmacother, 36, 1204, 10.1345/aph.1A396 Man, 2015, Regulation of inflammasome activation, Immunol Rev, 265, 6, 10.1111/imr.12296 Speck Desu, 2020, IC100: a novel anti-ASC monoclonal antibody improves functional outcomes in an animal model of multiple sclerosis, J Neuroinflammation, 17, 143, 10.1186/s12974-020-01826-0 Lu COBIiicKCYLS Leite, 2019, Efficacy of diacerein in reducing liver steatosis and fibrosis in patients with type 2 diabetes and non-alcoholic fatty liver disease: a randomized, placebo-controlled trial, Diabetes Obes Metabol, 21, 1266, 10.1111/dom.13643 Torina, 2015, Diacerein improves left ventricular remodeling and cardiac function by reducing the inflammatory response after myocardial infarction, PLoS One, 10, e0121842, 10.1371/journal.pone.0121842 Domiciano, 2017, Quercetin inhibits inflammasome activation by interfering with ASC oligomerization and prevents interleukin-1 mediated mouse vasculitis, Sci Rep, 7, 41539, 10.1038/srep41539 Boxer, 2010, A highly potent and selective caspase 1 inhibitor that utilizes a key 3-cyanopropanoic acid moiety, ChemMedChem, 5, 730, 10.1002/cmdc.200900531 Wannamaker, 2007, J Pharmacol Exp Therapeut, 321, 509, 10.1124/jpet.106.111344 MacKenzie, 2010, The potential for caspases in drug discovery, Curr Opin Drug Discov Dev, 13, 568 Yang, 2019, Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors, Cell Death Dis, 10, 128, 10.1038/s41419-019-1413-8 Sharif, 2019, Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome, Nature, 570, 338, 10.1038/s41586-019-1295-z Coll, 2019, MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition, Nat Chem Biol, 15, 556, 10.1038/s41589-019-0277-7 Zahid, 2019, Pharmacological inhibitors of the NLRP3 inflammasome, Front Immunol, 10, 2538, 10.3389/fimmu.2019.02538 Qu, 2019, The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice, Int Immunopharm, 70, 147, 10.1016/j.intimp.2019.02.016 Frissen, 2021, Bidirectional role of NLRP3 during acute and chronic cholestatic liver injury, Hepatology, 73, 1836, 10.1002/hep.31494 Gordon, 2018, Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice, Sci Transl Med, 10, eaah4066, 10.1126/scitranslmed.aah4066 He, 2014, 3,4-Methylenedioxy-β-nitrostyrene inhibits NLRP3 inflammasome activation by blocking assembly of the inflammasome, J Biol Chem, 289, 1142, 10.1074/jbc.M113.515080 Chang, 2018, β-nitrostyrene derivatives attenuate LPS-mediated acute lung injury via the inhibition of neutrophil-platelet interactions and NET release, Am J Physiol Lung Cell Mol Physiol, 314, L654, 10.1152/ajplung.00501.2016 Jiang, 2017, Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders, J Exp Med, 214, 3219, 10.1084/jem.20171419 Wang, 2021, NLRP3 inflammasome inhibitor CY-09 reduces hepatic steatosis in experimental NAFLD mice, Biochem Biophys Res Commun, 534, 734, 10.1016/j.bbrc.2020.11.009 Youm, 2015, The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease, Nat Med, 21, 263, 10.1038/nm.3804 Chen, 2018, β-Hydroxybutyrate protects from alcohol-induced liver injury via a Hcar2-cAMP dependent pathway, J Hepatol, 69, 687, 10.1016/j.jhep.2018.04.004 Lee, 2020, β-Hydroxybutyrate suppresses lipid accumulation in aged liver through GPR109A-mediated signaling, Aging Dis, 11, 777, 10.14336/AD.2019.0926 Han, 2020, β-hydroxybutyrate and its metabolic effects on age-associated pathology, Exp Mol Med, 52, 548, 10.1038/s12276-020-0415-z Lamkanfi, 2009, Glyburide inhibits the cryopyrin/Nalp3 inflammasome, J Cell Biol, 187, 61, 10.1083/jcb.200903124 Arriola Benitez, 2020, Brucella abortus infection elicited hepatic stellate cell-mediated fibrosis through inflammasome-dependent IL-1β production, Front Immunol, 10, 3036, 10.3389/fimmu.2019.03036 Hughes, 2017, Bladder fibrosis during outlet obstruction is triggered through the NLRP3 inflammasome and the production of IL-1β, Am J Physiol Ren Physiol, 313, F603, 10.1152/ajprenal.00128.2017 Juliana, 2010, Anti-inflammatory compounds parthenolide and bay 11-7082 are direct inhibitors of the inflammasome, J Biol Chem, 285, 9792, 10.1074/jbc.M109.082305 Terlizzi, 2016, IL-1α and IL-1β-producing macrophages populate lung tumor lesions in mice, Oncotarget, 7, 58181, 10.18632/oncotarget.11276 Kim, 2012, Parthenolide-induced apoptosis of hepatic stellate cells and anti-fibrotic effects in an in vivo rat model, Exp Mol Med, 44, 448, 10.3858/emm.2012.44.7.051 Zhang, 2020, Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway, Int Immunopharm, 78, 106064, 10.1016/j.intimp.2019.106064 Li, 2018, Parthenolide attenuated bleomycin-induced pulmonary fibrosis via the NF-κB/Snail signaling pathway, Respir Res, 19, 111, 10.1186/s12931-018-0806-z Marchetti, 2018, OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation, Proc Natl Acad Sci U S A, 115, E1530, 10.1073/pnas.1716095115 Said, 2012, Tranilast ameliorates impaired hepatic functions in Schistosoma mansoni-infected mice, Inflammopharmacology, 20, 77, 10.1007/s10787-011-0117-1 Kato, 2020, Tranilast inhibits pulmonary fibrosis by suppressing TGFβ/SMAD2 pathway, Drug Des Dev Ther, 14, 4593, 10.2147/DDDT.S264715 Luo, 2013, Role and mechanism of tranilast preventing the progression of tubulointerstilial fibrosis in diabetic kidney diseases, Zhong Nan Da Xue Xue Bao Yi Xue Ban, 38, 1233 Kaneyama, 2010, Tranilast modulates fibrosis, epithelial-mesenchymal transition and peritubular capillary injury in unilateral ureteral obstruction rats, Pathology, 42, 564, 10.3109/00313025.2010.508784 Liu, 2020, Oridonin ameliorates carbon tetrachloride-induced liver fibrosis in mice through inhibition of the NLRP3 inflammasome, Drug Dev Res, 81, 526, 10.1002/ddr.21649 Bohanon, 2014, Oridonin inhibits hepatic stellate cell proliferation and fibrogenesis, J Surg Res, 190, 55, 10.1016/j.jss.2014.03.036 Fu, 2018, Oridonin inhibits myofibroblast differentiation and bleomycin-induced pulmonary fibrosis by regulating transforming growth factor β (TGFβ)/Smad pathway, Med Sci Mon Int Med J Exp Clin Res, 24, 7548 Gao, 2021, The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice, Int Immunopharm, 90, 107133, 10.1016/j.intimp.2020.107133 Liu, 2013, A novel benzo[d]imidazole derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of NLRP3 inflammasome, Biochem Pharmacol, 85, 1504, 10.1016/j.bcp.2013.03.008 Byass, 2014, The global burden of liver disease: a challenge for methods and for public health, BMC Med, 12, 159, 10.1186/s12916-014-0159-5 Cross, 2020, Could an NLRP3 inhibitor be the one drug to conquer common diseases?, C&EN Global Enterprise El-Sharkawy, 2020, Inhibiting the NLRP3 inflammasome, Molecules, 25, 5533, 10.3390/molecules25235533